Summary
The noradrenaline content of the rat submaxillary gland was determined fluorimetrically as various times after sympathetic denervation as well as after the subcutaneous injection of reserpine (300 μg/kg). The effect of an adrenergic neurone blocker (β-TMIO) was compared with that of an inhibitor of monoamine oxidase (pargyline).
-
2
Both βTM10 (50 mg/kg s.c. given 6 hours and repeated 12 hours after the operation) and pargyline (100 mg/kg i.p. at the operation) delayed the decline of endogenous noradrenaline observed after denervation; the delay was similar for both treatments.
-
3.
Both,β-TM10 (50 mg/kg s.c. 2 hours before reserpine) and pargyline (100 mg/kg s.c. 6 hours before reserpine), caused a similar delay in the reserpine-induced decline of endogenous noradrenaline in the sympathetically decentralized gland.
-
4.
Reserpine induced a higher rate of depletion in normal than in decentralized glands of untreated or pargyline-pretreated rats. However, the relation of depletion rates was reversed afterβ-TM10.
-
5.
It is concluded that the last mentioned effect is at least partly due to the adrenergic neurone blocking effect ofβ-TMIO. The antagonism byβ-TMIO of the depleting effect of sympathetic denervation and of reserpine, on the other hand, is attributed to the ability of adrenergic neurone blocking agents to block monoamine oxidase. The results confirm earlier studies and indicate that the ability of adrenergic neurone blocking agents to block intraneuronal monoamine oxidase accounts for effects which up to now have been ascribed to their ability to prevent the release of noradrenaline by nerve impulses.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Axelrod, J., Hertting, G., Patrick, R. W.: Inhibition of H3-norepinephrine release by monoamine oxidase inhibitors. J. Pharmacol. exp. Ther.134, 325–328 (1961).
Benmiloud, M., Euler, U. S., von: Effects of bretylium, reserpine, guanethidine and sympathetic denervation on the noradrenaline content of the rat submaxillary gland. Acta physiol. scand.59, 34–42 (1963).
Bhagat, B.: The effect of adrenergic neurone blocking agents on the release and uptake of catecholamines by the rat heart. Arch. int. Pharmacodyn.146, 231–237 (1963).
Callingham, B. A., Cass, R.: The effect of bretylium and cocaine on noradrenaline depletion. J. Pharmacol. exp. Ther.14, 385–389 (1962).
Crout, J. R.: Catechol amines in urine. In: Standard Methods of Clinical Chemistry, Vol. 3, pp. 62–80. Ed.: D. Seligson. New York: Academic Press 1961.
Furchgott, R. F., Sanchez-Garcia, P.: Inhibition of monoamine oxidase of adrenergic nerve terminals by bretylium. Pharmacologist8, 176 (1966).
Giachetti, A., Shore, P. A.: Monoamine oxidase inhibition in the adrenergic neuron by bretylium, debrisoquin, and other adrenergic neuronal blocking agents. Biochem. Pharmacol.16, 237–238 (1967).
Haeusler, G., Haefely, W., Huerlimann, A.: On the mechanism of the adrenergic nerve blocking action of bretylium. Naunyn-Schmiedebergs Arch. Pharmak.265, 260–277 (1969).
Hertting, G., Axelrod, J., Patrick, R. W.: Action of bretylium and guanethidine on the uptake and release of H3-noradrenaline. Brit. J. Pharmacol.18, 161–166 (1962).
Langer, S. Z.: The degeneration contraction of the nictitating membrane in the unanesthetized cat. J. Pharmacol. exp. Ther.151, 66–72 (1966).
Lundberg, D.: Adrenergic neuron blockers and transmitter release after sympathetic denervation studied in the conscious rat. Acta physiol. scand.75, 415 to 426 (1969).
Malmfors, T., Sachs, C.: Direct studies on the disappearance of the transmitter and changes in the uptake-storage mechanism of degenerating adrenergic nerves. Acta physiol. scand.64, 211–223 (1965).
McLean, R. A., Geus, R. G., Pasternack, J., Mattis, P. A., Ullyot, G. E.: Pharmacology of trimethyl[2-(2.6-dimethylphenoxy)propyl]trimethylammonium chloride monohydrate; compound 6890 orβ-TM10. J. Pharmacol. exp. Ther.129, 17–23 (1960).
Noble, B.: Numerisches Rechnen, Bd. 88, S. 94–100. Mannheim: Bibl. Institut 1964.
Nordenfeit, I.: Cholinesterase in the submaxillary gland of the rat after sympathetic denervation. Quart. J. Physiol.53, 6–9 (1968).
Pluchino, S., Orden III, L. S., van, Draskoczy, P. R., Langer, S. Z., Trendelenburg, U.: The effect ofβ-TM10 on the pharmacological, biochemical and morphological changes induced by denervation of the nictitating membrane of the cat. J. Pharmacol. exp. Ther. (in press).
Ryd, G.: Protective effect of bretylium on noradrenaline stores in organs. Acta physiol. scand.56, 90–93 (1962).
Sedvall, G.: Short term effects of reserpine on noradrenaline levels in skeletal muscle. Acta physiol. scand.62, 101–108 (1964).
Winne, D.: Zur Auswertung von Versuchsergebnissen: Die Prüfung, ob Kurven sich in ihrem Verlauf unterscheiden. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.250, 383–396 (1965).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hennemann, HM., Trendelenburg, U. Effect of the adrenergic neurone blocker, β-TM 10, on the depletion of noradrenaline induced by denervation or reserpine. Naunyn-Schmiedebergs Arch. Pharmak. 265, 363–371 (1970). https://doi.org/10.1007/BF00997194
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00997194